RICCHETTI INCORPORATED for GLAXOSMITHKLINE INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2021 | $60,000 | Replaced |
| 1st Quarter - Amendment | Jul 20, 2021 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to drug pricing and Medicare and Medicaid reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Pharmacy PHA
Issues related to Covid-19 antibody treatment approval; Issues related to pharmaceutical industry, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.